Product Image

Contributor Information

  • Name Ayham Alnabulsi
  • Institute Vertebrate Antibodies Limited

Tool Details

  • Tool name: Anti-BCLAF1 [M33-P5B11]
  • Clone: M33-P5B11
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB ; ELISA ; IHC ; WB
  • Strain: Balb/c
  • Description: BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.
  • Immunogen: Peptide Sequence - KYQGDGIVED (amino acids 900 909)
  • Isotype: IgG1 kappa
  • Research area: Apoptosis and autophagy; Cancer; Genetics

  • For Research Use Only

Target Details

  • Target: BCL2 Associated Transcription Factor 1 (BCLAF1)
  • Target background: BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.

Application Details

  • Application: IHC ; WB ; ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

Related Tools

Product Image

Anti-HLADR [LHM 4]

#151117
Product Image

Anti-integrin a3 inhibiting

#161656
Product Image

Anti-Cytochrome P450 26A1 [F27P6A1]

#152114

References

  • •  Brown et al. 2016. Histopathology. 68(4):556-66. PMID: 26183150.
  • •  The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.